Global Heparin Industry 2017 Market Research Report

Publisher Name :
Date: 13-Nov-2017
No. of pages: 147
Inquire Before Buying

This report studies the Heparin market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Heparin market by product type and applications/end industries.

In the last several years, Global market of Heparin developed rapidly, with an average growth rate of 3.3%. In 2016, Global Revenue of Heparin is nearly 910 M USD; the actual production is about 39000 billion units.

The major players in global Heparin market include

Hepalink

Changshan Pharm

Qianhong Bio-pharma

Opocrin

Pfizer

Aspen Oss

King-friend Biochemical Pharmaceutical

Bioibérica

Dongcheng Biochemicals

Jiulong Biochemicals

Tiandong

Xinbai

Yino Pharma Limited

Deebio

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Heparin in these regions, from 2012 to 2022 (forecast), covering

United Stated

China

Europe

Japan

Rest of Asia

Rest of World

On the basis of product, the Heparin market is primarily split into

Heparin Sodium

Heparin Calcium

Other

On the basis on the end users/applications, this report covers

UFH

LMWH

Global Heparin Industry 2017 Market Research Report

Table of Contents
1 Heparin Market Overview 1
1.1 Product Overview and Scope of Heparin 1
1.2 Heparin Segment by Type 2
1.2.1 Global Production Market Share of Heparin by Type 2
1.2.2 Global Heparin Sales Market Share by Types in 2016 2
1.2.3 Heparin Sodium 3
1.2.4 Heparin Calcium 3
1.3 Heparin Segment by Application 4
1.3.1 Heparin Sales Market Share by Application 4
1.3.2 Mainly Used of Heparin 5
1.4 Global Heparin Market by Regions (2012-2022F) 6
1.4.1 Global Heparin Market Size (Value) and CAGR (%) Comparison by Regions (2012-2022F) 6
1.4.2 USA Heparin Status and Prospect (2012-2022F) 6
1.4.3 China Heparin Status and Prospect (2012-2022F) 7
1.4.4 Europe Heparin Status and Prospect (2012-2022F) 7
1.4.5 India Heparin Status and Prospect (2012-2022F) 8
1.4.6 Rest of Asia Heparin Status and Prospect (2012-2022F) 9
1.4.7 Rest of World Heparin Status and Prospect (2012-2022F) 10
1.5 Global Market Size (Value) of Heparin (2012-2022F) 11
1.5.1 Global Heparin Revenue Status and Outlook (2012-2022F) 11
1.5.2 Global Heparin Sales Status and Outlook (2012-2022F) 13
2 Global Heparin Market Competition by Manufacturers 14
2.1 Global Heparin Sales and Share by Manufacturers (2016-2017E) 14
2.2 Global Heparin Revenue and Share by Manufacturers (2016-2017E) 16
2.3 Global Heparin Average Price by Manufacturers (2016-2017E) 19
2.4 Manufacturers Heparin Headquarters, Established Date 20
2.5 Heparin Market Competitive Situation and Trends 21
2.5.1 Heparin Market Share of Top 3 and Top 5 Manufacturers 21
2.5.2 Mergers & Acquisitions, Expansion 22
2.5.3 Mergers & Acquisitions, Expansion 22
3 Global Heparin Sales, Revenue by Regions (2016-2017E) 24
3.1 Global Heparin Sales and Market Share by Regions (2012-2017E) 24
3.2 Global Heparin Revenue and Market Share by Regions (2012-2017E) 26
3.3 Global Heparin Sales, Revenue and Average Price (2012-2017E) 28
3.4 USA Heparin Sales, Revenue and Average Price (2012-2017E) 29
3.5 Europe Heparin Sales, Revenue and Average Price (2012-2017E) 29
3.6 China Heparin Sales, Revenue and Average Price (2012-2017E) 29
3.7 India Heparin Sales, Revenue and Average Price (2012-2017E) 30
3.8 Rest of Asia Heparin Sales, Revenue and Average Price (2012-2017E) 30
3.9 Rest of World Heparin Sales, Revenue and Average Price (2012-2017E) 30
4 Global Heparin Supply (Production), Consumption, Export, Import by Regions (2012-2017E) 31
4.1 Global Heparin Production by Regions (2012-2017E) 31
4.2 USA Heparin Production, Consumption, Export, Import (2012-2017E) 33
4.3 Europe Heparin Production, Consumption, Export, Import (2012-2017E) 34
4.4 China Heparin Production, Consumption, Export, Import (2012-2017E) 34
5 Global Heparin Sales by Types 35
5.1 Global Heparin Sales and Market Share by Types (2012-2017E) 35
5.2 Global Heparin Sales Growth by Type (2012-2017E) 38
6 Global Heparin Market Analysis by Applications 39
6.1 Global Heparin Consumption and Market Share by Applications (2012-2017E) 39
6.2 Global Heparin Consumption Growth Rate by Applications (2012-2017E) 42
7 Major Manufacturers Analysis of Heparin 43
7.1 Hepalink 43
7.1.1 Company Profile 43
7.1.2 Product Picture and Specifications 44
7.1.3 Sales, Price, Gross Margin and Revenue 44
7.1.4 Contact Information 45
7.2 Changshan Biochemical 45
7.2.1 Company Profile 45
7.2.2 Product Picture and Specifications 46
7.2.3 Sales, Price, Gross Margin and Revenue 47
7.2.4 Contact Information 47
7.3 Qianhong Bio-pharma 47
7.3.1 Company Profile 47
7.3.2 Product Picture and Specifications 48
7.3.3 Sales, Price, Gross Margin and Revenue 48
7.3.4 Contact Information 49
7.4 Opocrin 49
7.4.1 Company Profile 49
7.4.2 Product Specifications 49
7.4.3 Sales, Price, Gross Margin and Revenue 50
7.4.4 Contact Information 50
7.5 Pfizer 50
7.5.1 Company Profile 50
7.5.2 Product Picture 51
7.5.3 Sales, Price, Gross Margin and Revenue 51
7.5.4 Contact Information 52
7.6 Aspen Oss 52
7.6.1 Company Profile 52
7.6.2 Product Specifications 52
7.6.3 Sales, Price, Gross Margin and Revenue 53
7.6.4 Contact Information 53
7.7 King-friend Biochemical Pharmaceutical 53
7.7.1 Company Profile 54
7.7.2 Product Picture and Specifications 54
7.7.3 Sales, Price, Gross Margin and Revenue 55
7.7.4 Contact Information 56
7.8 Bioibérica 56
7.8.1 Company Profile 56
7.8.2 Product Picture 57
7.8.3 Sales, Price, Gross Margin and Revenue 57
7.8.4 Contact Information 57
7.9 Dongcheng Biochemicals 57
7.9.1 Company Profile 58
7.9.2 Product Picture and Specifications 58
7.9.3 Sales, Price, Gross Margin and Revenue 59
7.9.4 Contact Information 59
7.10 Jiulong Biochemicals 59
7.10.1 Company Profile 60
7.10.2 Product Picture 60
7.10.3 Sales, Price, Gross Margin and Revenue 61
7.10.4 Contact Information 61
7.11 Tiandong 61
7.11.1 Company Profile 61
7.11.2 Product Picture and Specifications 62
7.11.3 Sales, Price, Gross Margin and Revenue 63
7.11.4 Contact Information 63
7.12 Xinbai 63
7.12.1 Company Profile 63
7.12.2 Product Picture 64
7.12.3 Sales, Price, Gross Margin and Revenue 64
7.12.4 Contact Information 64
7.13 Yino Pharma Limited 64
7.13.1 Company Profile 65
7.13.2 Product Picture 65
7.13.3 Sales, Price, Gross Margin and Revenue 66
7.13.4 Contact Information 66
7.14 Deebio 66
9.14.1 Company Profile 66
7.14.2 Product Picture and Specifications 67
7.14.3 Sales, Price, Gross Margin and Revenue 68
7.14.4 Contact Information 69
8 Heparin Manufacturing Cost Analysis 70
8.1 Heparin Key Raw Materials Analysis 70
8.1.1 Key Raw Materials 70
8.1.2 Price Trend of Key Raw Materials 71
8.1.3 Global Swine Stock Analysis 72
8.1.4 Utilization Rate of Pig Small Intestine in China 74
8.2 Proportion of Manufacturing Cost Structure 74
8.2.1 Raw Materials 74
8.2.2 Labor Cost 75
8.2.3 Manufacturing Expenses 80
8.2.4 Other Costs Analysis 80
8.3 Manufacturing Process Analysis of Heparin 86
9 Industrial Chain, Sourcing Strategy and Downstream Buyers 87
9.1 Heparin Industrial Chain Analysis 87
9.2 Upstream Raw Materials Sourcing 87
9.3 Downstream Buyers 88
10 Marketing Strategy Analysis, Distributors/Traders 90
10.1 Marketing Channel 90
10.1.1 Direct Marketing 90
10.1.2 Indirect Marketing 91
10.1.3 Marketing Channel Development Trend 92
10.2 Market Positioning 92
10.2.1 Pricing Strategy 92
10.2.2 Brand Strategy 93
10.3 Distributors/Traders List 94
11 Market Effect Factors Analysis 95
11.1 Technology Progress/Risk 95
11.1.1 Substitutes Threat 95
11.1.2 Technology Progress in Related Industry 95
11.2 Consumer Needs/Customer Preference Change 95
11.3 Economic/Political Environmental Change 96
12 Global Heparin Market Forecast (2017E-2022F) 104
12.1 Global Heparin Sales, Revenue Forecast (2017E-2022F) 104
12.1.1 Global Heparin Sales and Growth Rate Forecast (2017E-2022F) 104
12.1.2 Global Heparin Revenue and Growth Rate Forecast (2017E-2022F) 105
12.1.3 Global Heparin Price and Trend Forecast (2017E-2022F) 106
12.2 Global Heparin Production, Sales, Revenue and Growth Rate Forecast by Regions (2017E-2022F) 106
12.2.1 Global Heparin Production Forecast by Regions (2017E-2022F) 106
12.2.2 Global Heparin Sales and Growth Rate Forecast by Regions (2017E-2022F) 108
12.2.3 Global Heparin Revenue and Growth Rate Forecast by Regions (2017E-2022F) 110
12.2.4 United Stated Heparin Sales, Revenue and Growth Rate Forecast (2017E-2022F) 113
12.2.5 Europe Heparin Sales, Revenue and Growth Rate Forecast (2017E-2022F) 115
12.2.6 China Heparin Sales, Revenue and Growth Rate Forecast (2017E-2022F) 117
12.2.7 India Heparin Sales, Revenue and Growth Rate Forecast (2017E-2022F) 119
12.2.8 Rest of Asia Heparin Sales, Revenue and Growth Rate Forecast (2017E-2022F) 120
12.2.9 Rest of World Heparin Sales, Revenue and Growth Rate Forecast (2017E-2022F) 122
12.3 Global Heparin Sales Forecast by Type (2017E-2022F) 123
12.4 Global Heparin Sales Forecast by Application (2017E-2022F) 124
13 Research Findings and Conclusion 126
14 Appendix 127
14.1 Methodology/Research Approach 127
14.1.1 Research Programs/Design 127
14.1.2 Market Size Estimation 128
14.1.3 Market Breakdown and Data Triangulation 129
14.2 Data Source 130
14.2.1 Secondary Sources 130
14.2.2 Primary Sources 131
14.3 Disclaimer 132
14.4 Author List 134
List of Tables and Figures
Figure Picture of Heparin 1
Table Heparin Specifications of Qianhong Bio-pharma 1
Table Global Heparin Sales (B Units) and Growth Rate Comparison by Types (2012-2022) 2
Figure Global Production Market Share of Heparin by Type in 2016 2
Figure Heparin Sodium Product Picture 3
Figure Heparin Calcium Product Picture 3
Table Detailed Description of Heparin API 4
Table Global Heparin Sales (B Units) Comparison by Applications (2012-2022) 4
Figure Heparin Sales Market Share by Application in 2016 5
Table Applications of Heparin 5
Figure Global Heparin Market Size (Million USD) Comparison and CAGR (%) by Regions (2012-2022F) 6
Figure USA Heparin Revenue (Million USD) and Growth Rate (2012-2022F) 6
Figure China Heparin Revenue (Million USD) and Growth Rate (2012-2022F) 7
Figure Europe Heparin Revenue (Million USD) and Growth Rate (2012-2022F) 7
Figure India Heparin Revenue (Million USD) and Growth Rate (2012-2022F) 8
Figure Rest of Asia Heparin Revenue (Million USD) and Growth Rate (2012-2022F) 9
Figure Rest of World Heparin Revenue (Million USD) and Growth Rate (2012-2022F) 10
Figure Global Heparin Revenue (Million USD) Status and Outlook (2012-2022F) 11
Figure Hepalink Heparin API Average Price (USD/B Units) 2013~2016 12
Figure Global Heparin Sales (B Units) Status and Outlook (2012-2022F) 13
Table Global Heparin Sales (B Units) of Key Manufacturers (2016-2017E) 14
Table Global Heparin Sales Share by Manufacturers (2016-2017E) 14
Figure 2016 Global Heparin Sales Share by Players 15
Figure 2017 Global Heparin Sales Share by Players 16
Table Global Heparin Revenue (M USD) by Players (2016-2017) 16
Table Global Heparin Revenue Share by Players (2016-2017) 17
Figure 2016 Global Heparin Revenue Share by Players 18
Figure 2017E Global Heparin Revenue Share by Players 19
Table Global Market Heparin Average Price (USD/B Units) of Key Manufacturers (2016-2017E) 19
Table Headquarters and Established Date of Global Heparin Major Manufacturers in 2016 20
Figure Heparin Sales Market Share of Top 3 Manufacturers 21
Figure Heparin Sales Market Share of Top 5 Manufacturers 22
Table Mergers & Acquisitions, Expansion List of Heparin 22
Table Global Heparin Sales (B Units) by Regions (2012-2017E) 24
Table Global Heparin Sales and Market Share by Regions (2012-2017E) 24
Figure 2016 Global Heparin Sales Market Share by Regions 25
Figure 2017E Global Heparin Sales Market Share by Regions 26
Table Global Heparin Revenue (Million USD) by Regions (2012-2017E) 26
Table Global Heparin Revenue Market Share by Regions (2012-2017E) 27
Figure 2016 Global Heparin Revenue Market Share by Regions 27
Figure 2017E Global Heparin Revenue Market Share by Regions 28
Table Global Heparin Sales, Revenue and Average Price (2012-2017E) 28
Table USA Heparin Sales, Revenue and Average Price (2012-2017E) 29
Table Europe Heparin Sales, Revenue and Average Price (2012-2017E) 29
Table China Heparin Sales, Revenue and Average Price (2012-2017E) 29
Table India Heparin Sales, Revenue and Average Price (2012-2017E) 30
Table Rest of Asia Heparin Sales, Revenue and Average Price (2012-2017E) 30
Table Rest of World Heparin Sales, Revenue and Average Price (2012-2017E) 30
Table Global Heparin Production Market by Regions (2012-2017E) 31
Table Global Heparin Production Market Share by Regions (2012-2017E) 31
Figure 2016 Global Heparin Consumption Market Share by Regions 32
Figure 2017E Global Heparin Consumption Market Share by Regions 33
Table USA Heparin Production, Consumption, Import & Export (2012-2017E) 33
Table Europe Heparin Production, Consumption, Import & Export (2012-2017E) 34
Table China Heparin Production, Consumption, Import & Export (2012-2017E) 34
Table Global Heparin Sales (B Units) by Types (2012-2017E) 35
Table Global Heparin Sales Share by Types (2012-2017E) 35
Figure Sales Market Share of Heparin by Types (2012-2017E) 36
Figure 2016 Sales Market Share of Heparin by Types 37
Figure Global Heparin Sales Growth by Type (2012-2017E) 38
Table Global Heparin Consumption (B Units) by Applications (2012-2017E) 39
Table Global Heparin Consumption Market Share by Applications (2012-2017E) 39
Figure Global Heparin Consumption Market Share by Applications (2012-2017E) 40
Figure Global Heparin Consumption Market Share by Applications in 2016 41
Figure Global Heparin Consumption Growth Rate by Applications (2012-2017E) 42
Table Hepalink Information List 43
Figure Heparin Picture of Hepalink 44
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Hepalink 2016-2017 44
Table Changshan Biochemical Information List 45
Figure Heparin Picture of Changshan Biochemical 46
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Changshan Biochemical 2016-2017 47
Table Qianhong Bio-pharma Information List 47
Figure Heparin Picture of Qianhong Bio-pharma 48
Table Heparin Specifications of Qianhong Bio-pharma 48
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Qianhong Bio-pharma 2016-2017 48
Table Opocrin Information List 49
Table Heparin Specifications of Opocrin 49
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Opocrin 2016-2017 50
Table Pfizer Information List 50
Figure Heparin Picture of Pfizer 51
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Pfizer 2016-2017 51
Table Aspen Oss Information List 52
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Aspen Oss 2016-2017 53
Table King-friend Biochemical Pharmaceutical Information List 54
Figure Heparin Picture of King-friend Biochemical Pharmaceutical 54
Table Heparin Specifications of King-friend Biochemical Pharmaceutical 55
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of King-friend Biochemical Pharmaceutical 2016-2017 55
Table Bioibérica Information List 56
Figure Heparin Picture of Bioibérica 57
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Bioibérica 2016-2017 57
Table Dongcheng Biochemicals Information List 58
Figure Heparin Picture of Dongcheng Biochemicals 58
Table Heparin Specifications of Dongcheng Biochemicals 59
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Dongcheng Biochemicals 2016-2017 59
Table Jiulong Biochemicals Information List 60
Figure Heparin Picture of Jiulong Biochemicals 60
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Jiulong Biochemicals 2016-2017 61
Table Tiandong Information List 61
Figure Heparin Picture of Tiandong 62
Table Heparin Specifications of Tiandong 62
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Tiandong 2016-2017 63
Table Xinbai Information List 63
Figure Heparin Picture of Xinbai 64
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Xinbai 2016-2017 64
Table Yino Pharma Limited Information List 65
Figure Heparin Picture of Yino Pharma Limited 65
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Yino Pharma Limited 2016-2017 66
Table Deebio Information List 66
Figure Heparin Picture of Deebio 67
Table Heparin Specifications of Deebio 68
Table Heparin Sales (B Units), Average Price (USD/B Units), Revenue (Million USD) and Gross Margin of Deebio 2016-2017 68
Table Key Raw Materials 70
Figure Price Trend of Heparin Crude (RMB/Billion IU) 71
Table Swine Stocks and Production Selected Countries (1000 Head) 72
Table Cattle Stocks and Production Selected Countries (1000 Head) 73
Figure Utilization Rate of Pig Small Intestine in China 74
Table Manufacturing Cost Structure of Heparin 74
Figure Brazil Overview of Average Monthly Wages 2016-2017 (BRL/Month) 75
Figure Argentina Overview of Average Monthly Wages 2012-2016 (ARS/Month) 75
Figure Mexico Overview of Average Monthly Wages 2012-2016(MXN/Day) 76
Figure USA Labor Cost Analysis 76
Figure Cost of Employing a Factory Worker 78
Figure 2016 Estimated Labour Costs for the Whole Economy in EuropeR 79
Figure Monthly Minimum Wages in Asia 2016 79
Figure China Labor Costs 80
Table Average Price of Electricity to Ultimate Customers 81
Figure Electricity Prices for Household Consumers in 2016 83
Figure Summary of the Driving Assumptions 84
Figure Industrial Electric Rates 2016 (PER KWH) 84
Figure Manufacturing Process Analysis of Heparin 86
Figure Heparin Industrial Chain Analysis 87
Table Major Buyers of Heparin 88
Figure Market Channel of Heparin 92
Table Distributors/Traders List 94
Figure Global GDP Growth Rate for 2016 96
Figure US GDP 2006-2016 (Billion USD) 97
Figure US CPI Change 2016-2017 98
Figure EU GDP 2006-2016 (Billion USD) 98
Figure EU CPI Change 2012-2016 99
Figure Germany GDP 2006-2016 (Billion USD) 99
Figure UK GDP 2006-2016 (Billion USD) 100
Figure UK CPI Change 2016-2017 100
Figure Italy GDP 2006-2016 (Billion USD) 101
Figure Italy CPI Change 2016-2017 101
Figure Japan GDP 2006-2016 (Billion USD) 102
Figure Japan CPI Change 2012-2016 102
Figure China GDP 2006-2016 (Billion USD) 103
Figure China CPI Change 2016-2017 103
Figure Global Heparin Sales (B Units) and Growth Rate Forecast (2017E-2022F) 104
Figure Global Heparin Revenue (M USD) and Growth Rate Forecast (2017E-2022F) 105
Figure Global Heparin Price (USD/B Units) and Trend Forecast (2017E-2022F) 106
Table Global Heparin Production (B Units) Forecast by Regions (2017E-2022F) 106
Table Global Heparin Production Market Share Forecast by Regions (2017E-2022F) 107
Figure Global Heparin Production Market Share Forecast by Regions (2017E-2022F) 107
Figure Global Heparin Production Market Share Forecast by Regions in 2022F 108
Table Global Heparin Sales (B Units) Forecast by Regions (2017E-2022F) 108
Figure Global Heparin Sales Market Share Forecast by Regions (2017E-2022F) 109
Figure Global Heparin Sales Market Share Forecast by Regions in 2022 110
Table Global Heparin Revenue (M USD) Forecast by Regions (2017E-2022F) 110
Figure Global Heparin Revenue Market Share Forecast by Regions (2017E-2022F) 111
Figure Global Heparin Revenue Market Share Forecast by Regions in 2022 112
Figure United Stated Heparin Sales (B Units) and Growth Rate Forecast (2017E-2022F) 113
Figure United Stated Heparin Revenue (M USD) and Growth Rate Forecast (2017E-2022F) 114
Figure Europe Heparin Sales (B Units) and Growth Rate Forecast (2017E-2022F) 115
Figure Europe Heparin Revenue (M USD) and Growth Rate Forecast (2017E-2022F) 116
Figure China Heparin Sales (B Units) and Growth Rate Forecast (2017E-2022F) 117
Figure China Heparin Revenue (M USD) and Growth Rate Forecast (2017E-2022F) 118
Figure India Heparin Sales (B Units) and Growth Rate Forecast (2017E-2022F) 119
Figure India Heparin Revenue (M USD) and Growth Rate Forecast (2017E-2022F) 119
Figure Rest of Asia Heparin Sales (B Units) and Growth Rate Forecast (2017E-2022F) 120
Figure Rest of Asia Heparin Revenue (M USD) and Growth Rate Forecast (2017E-2022F) 121
Figure Rest of World Heparin Sales (B Units) and Growth Rate Forecast (2017E-2022F) 122
Figure Rest of World Heparin Revenue (M USD) and Growth Rate Forecast (2017E-2022F) 123
Table Global Heparin Sales (B Units) Forecast by Type (2017E-2022F) 123
Figure Global Heparin Sales Market Share Forecast by Type (2017E-2022F) 124
Table Global Heparin Sales (B Units) Forecast by Application (2017E-2022F) 124
Figure Global Heparin Sales Market Share Forecast by Application (2017E-2022F) 125
Table Research Programs/Design for This Report 127
Figure Bottom-up and Top-down Approaches for This Report 129
Figure Data Triangulation 130
Table Key Data Information from Secondary Sources 131
Table Key Data Information from Primary Sources 132
  • Global and China Heparin Sodium Market Research by Company, Type & Application 2013-2025
    Published: 16-Nov-2017        Price: US 2000 Onwards        Pages: 105
    Summary Market Segment as follows: By Type - Type 1 - Type 2 - Type 3 By Application - Treatment of Venous Thromboembolism - Complications of Pregnancy - Cardioversion of Atrial Fibrillation/Flutter By Company - Shenzhen Hepalink - Bioibérica - Nanjing King-friend - Pfizer - SPL - Dongcheng Biochemicals - Changzhou Qianhong Bio-pharma - Cha......
  • Global Heparin Sodium Market Research Report 2017
    Published: 10-Nov-2017        Price: US 2900 Onwards        Pages: 141
    With increasing downstream demand, global heparin sodium API production also increased from 90768 Kg in 2007 to 138099 Kg in 2012. In 2007, the global market of heparin sodium was valued at 222 million USD. From 2007 to 2012, as the price of heparin sodium increasing, global heparin sodium market has grown fivefold in market size. Over the past five years, the price of global heparin sodium has been declining. At present, the global heparin sodium market size is about 700 million USD. Global hep......
  • Global Low Molecular Weight Heparin Market Research Report 2017
    Published: 10-Nov-2017        Price: US 2900 Onwards        Pages: 107
    The global production of low molecular weight heparin increases from 12467 Kg in 2012 to 16852 Kg in 2016, at a CAGR of more than 7.82%. In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second's largest market with the share of 30.49%. This report studies Low Molecular Weight Heparin in Global market, especially in USA, Europe, China a......
  • Global Intravenous Immunoglobulin (IVIg) Market Research Report 2017
    Published: 09-Nov-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Intravenous Immunoglobulin (IVIg) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Intravenous Immunoglobulin (IVIg) in these regions, from 2012 to 2022 (forecast), covering - North America ......
  • Global and Regional Injectable Anticoagulants Market Research Report 2017
    Published: 09-Nov-2017        Price: US 3500 Onwards        Pages: 122
    Summary The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]).In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South Ameri......
  • Global and Regional Anticoagulants Market Research Report 2017
    Published: 09-Nov-2017        Price: US 3500 Onwards        Pages: 155
    Summary Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or t......
  • North America Fibrinogen Concentrates Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 09-Nov-2017        Price: US 4480 Onwards        Pages: 123
    Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer's product are justly used in local region or countries.......
  • Global Injectable Anticoagulants Market Research Report 2017
    Published: 08-Nov-2017        Price: US 2900 Onwards        Pages: 106
    In this report, the global Injectable Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Injectable Anticoagulants in these regions, from 2012 to 2022 (forecast), covering - North America - Europe ......
  • Asia-Pacific Heparin Sodium Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 08-Nov-2017        Price: US 4480 Onwards        Pages: 120
    Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Scope of the Report: This report focuses on the Heparin Sodium in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs